Justin Colarco, DPM
Podiatrist · Las Vegas, NVNPI 1952531378
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 94 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 8 manufacturers reported payments, led by Stryker at 31.5% of the total. Reporting peaked in 2020 at $656 and has fallen 55.6% since, to $291 in 2024.
Across 94 payments — averaging $25.07 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Stryker$743
- Goode Surgical Inc$520
- Trimed, Inc.$518
- Nevro Corp.$332
- Alafair Biosciences, Inc.$125
- Paragon 28, Inc.$57
- plus $61 from 2 others
What the payments were for
- Food & beverage$2,357100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Stryker(2 entities) | 49 | $743 |
| Goode Surgical Inc | 24 | $520 |
| Trimed, Inc. | 6 | $518 |
| Nevro Corp. | 10 | $332 |
| Alafair Biosciences, Inc. | 1 | $125 |
| Paragon 28, Inc. | 1 | $57 |
| Smoky Mountain Surgical LLC | 2 | $43 |
| Convatec Inc. | 1 | $18 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- VersaWrap$125
- CARTIVA$121
- Tools - WFS$111
How this compares
$2,357 in reported general payments places this provider in the 70th percentile of 44 podiatrist providers in Nevada.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Ciclopirox | 18 | $808 |
| Desipramine Hcl | 22 | $727 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 43 | $719 |
| Terbinafine Hcl | 23 | $396 |
| Gabapentin | 35 | $382 |
| Cilostazol | 12 | $163 |
| Meloxicam | 43 | $120 |
| Allopurinol | 11 | $114 |
| Nabumetone | 12 | $91 |
| Diclofenac Sodium | 13 | $72 |
| Indomethacin | 21 | $72 |
Paid to pharmacies, not to this prescriber.
Other podiatrist in Las Vegas
- Anthony RicciardiLas Vegas$498K
- Jeremy AndersonLas Vegas$72K
- He XuLas Vegas$54K
- Peter BregmanLas Vegas$18K
- Anmy VuLas Vegas$15K
- Ai Quoc HellerLas Vegas$8K
- John CadeLas Vegas$6K
- Ada VeraLas Vegas$5K
- Michael ChildsLas Vegas$4K
- Sofia HossainLas Vegas$1K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.